Literature DB >> 3111077

Immunohistological analysis of Rosai-Dorfman histiocytosis. A disease of S-100 + CD1-histiocytes.

F Bonetti, M Chilosi, F Menestrina, A Scarpa, P G Pelicci, E Amorosi, L Fiore-Donati, D M Knowles.   

Abstract

Five cases of Rosai-Dorfman histiocytosis (RDH) (also called Sinus Histiocytosis with Massive Lymphoadenopathy; SHML) have been studied by immunohistochemical methods with heteroantisera and monoclonal antibodies. One case was also studied by Southern blot hybridization analysis with DNA probes specific for T cell receptor beta chain and immunoglobulin heavy chain. Immunophenotyping of large histiocytes, characteristic of RDH, evidenced the presence of S-100 protein and the absence of CD1 and other markers usually found in histiocytes and macrophages. DNA hybridization study showed the absence of clonal T or B lymphoid populations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111077     DOI: 10.1007/bf00712736

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  43 in total

1.  Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity.

Authors:  L LICHTENSTEIN
Journal:  AMA Arch Pathol       Date:  1953-07

2.  Sinus histiocytosis with massive lymphadenopathy and unusual extranodal manifestations.

Authors:  R Mir; B Aftalion; L B Kahn
Journal:  Arch Pathol Lab Med       Date:  1985-09       Impact factor: 5.534

3.  Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases.

Authors:  J Rosai; R F Dorfman
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

4.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.

Authors:  S N Hanjan; J F Kearney; M D Cooper
Journal:  Clin Immunol Immunopathol       Date:  1982-05

5.  Malignant histiocytosis of the intestine: a T-cell lymphoma.

Authors:  P G Isaacson; N T O'Connor; J Spencer; D H Bevan; C E Connolly; N Kirkham; D J Pollock; J S Wainscoat; H Stein; D Y Mason
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

6.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

7.  Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.

Authors:  P Isaacson; D H Wright; D B Jones
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860

8.  A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno-and enzyme-histochemical characteristics.

Authors:  C A Feltkamp; P van Heerde; T M Feltkamp-Vroom; J Koudstaal
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Langerhans cell (eosinophilic) granulomatosis.

Authors:  P H Lieberman; C R Jones; D A Filippa
Journal:  J Invest Dermatol       Date:  1980-07       Impact factor: 8.551

10.  Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia.

Authors:  B A Zehnbauer; D M Pardoll; P J Burke; M L Graham; B Vogelstein
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

View more
  13 in total

1.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): clinico-pathological study of three cases.

Authors:  Mercedes Bernácer-Borja; Miriam Blanco-Rodríguez; Jose Manuel Sanchez-Granados; Rocío Benitez-Fuentes; Alicia Cazorla-Jimenez; Carmen Rivas-Manga
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

2.  Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case.

Authors:  M Paulli; F Locatelli; S Kindl; E Boveri; F Facchetti; F Porta; R Rosso; L Nespoli; U Magrini
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  W H McAlister; T Herman; L P Dehner
Journal:  Pediatr Radiol       Date:  1990

4.  Sinus histiocytosis with massive lymphadenopathy: immunological, cytogenetic and molecular studies.

Authors:  S Sacchi; T Artusi; L Selleri; P Temperani; P Zucchini; A Vecchi; G Emilia; U Torelli
Journal:  Blut       Date:  1990-06

5.  Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease) in an HIV-positive patient.

Authors:  F Delacrétaz; C Meugé-Moraw; D Anwar; B Borisch; J P Chave
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Sinus histiocytosis with massive lymphadenopathy Rosai-Dorfman: three unusual manifestations.

Authors:  Gudrun Ratzinger; Bettina Zelger; Walter Höbling; Gregor Mikuz; Bernhard W Zelger
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

Review 8.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

9.  Variable extent of emperipolesis in the evolution of Rosai Dorfman disease: Diagnostic and pathogenetic implications.

Authors:  Venkateswaran K Iyer; Kumud Kumar Handa; Mehar Chand Sharma
Journal:  J Cytol       Date:  2009-07       Impact factor: 1.000

10.  Sinus histiocytosis with massive lymphadenopathy: a case report with pleural effusion and cervical lymphadenopathy.

Authors:  Jinyung Ju; Yong Soo Kwon; Kae Jung Jo; Dong Ryeol Chae; Jung Hwan Lim; Hee Jung Ban; Su Young Chi; In Jae Oh; Ku Sik Kim; Yu Il Kim; Young Chul Kim; Sung Chul Lim
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.